Bildkälla: Stockfoto

Cantargia: First Patient in CESTAFOUR - Redeye

Redeye comments on Cantargia’s initiation of its planned chemotherapy combination trial.

Redeye comments on Cantargia’s initiation of its planned chemotherapy combination trial.
Börsvärldens nyhetsbrev
ANNONSER